Table 3 Utilization of medications to modify cardiometabolic health among men seen in the Heart Healthy Clinic
From: Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience
Use of cardiometabolic mediation at visit | Prevalence in cohort (n = 55) |
|---|---|
Statin | |
Yes | 33 (60%) |
No | 22 (40%) |
Anti-platelet therapy | |
Yes | 26 (47.3%) |
No | 29 (52.7%) |
Anti-hypertensive | |
Yes | 35 (63.6%) |
No | 20 (36.4%) |
Beta blocker | |
Yes | 16 (29.1%) |
No | 39 (70.9%) |
Metformin | |
Yes | 8 (14.5%) |
No | 47 (85.5%) |
Other diabetic medication | |
Yes | 10 (18.2%) |
No | 45 (81.8%) |